author-photo

Paul Giangrande

Churchill Hospital
University of Oxford

99

Papers

5357

Citations

Citation Trend

Filter By

Papers (63) Sort By

Journal Conference Others

Long-term safety and efficacy of N8-GP in previously treated adults and adolescents with hemophilia A: Final results from pathfinder2.

2020 Journal of Thrombosis and Haemostasis
Show All
- Source
- Cite
- Save
Citations (9)
Clinical evaluation of bleeds and response to haemostatic treatment in patients with acquired haemophilia: A global expert consensus statement

2019 Haemophilia
Show All
- Source
- Cite
- Save
Citations (11)
Guidelines for the management of acute joint bleeds and chronic synovitis in haemophilia: A United Kingdom Haemophilia Centre Doctors' Organisation (UKHCDO) guideline.

2017 Haemophilia
Show All
- Source
- Cite
- Save
Citations (40)
Title Page Enhanced pharmacokinetic properties of a glycoPEGylated recombinant factor IX: A first human dose trial in patients with hemophilia B Running Title

2017
Show All
- Source
- Cite
- Save
Citations (0)
the Economic Impact of Total Knee Replacement in Patients with Haemophilia and Inhibitors: Analysis from a Uk Payer Perspective : p087

2016 Haemophilia
Show All
- Source
- Cite
- Save
Citations (1)
The first Team Haemophilia Education meeting, 2015, Amsterdam, The Netherlands

2016 European Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (3)
Research in haemophilia B – approaching the request for high evidence levels in a rare disease

2015 Haemophilia
Show All
- Source
- Cite
- Save
Citations (2)
The Impact of Orthopaedic Surgery on The Quality of Life of Haemophilia Patients With or Without Inhibitors: A Systematic Review of The Literature.

2015 Value in Health
Show All
- Source
- Cite
- Save
Citations (0)
Recombinant activated factor VII in the treatment of bleeds and for the prevention of surgery-related bleeding in congenital haemophilia with inhibitors

2015 Blood Reviews
Show All
- Source
- Cite
- Save
Citations (17)
Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity.

2015 Journal of Thrombosis and Haemostasis
Show All
- Source
- Cite
- Save
Citations (40)